查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2034542

全球動物用藥品市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Veterinary Pharmaceuticals Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 213 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球動物用藥品市場預計將從2025年的417.2億美元成長至2034年的838.8億美元，2026年至2034年的複合年成長率（CAGR）為8.07%。該市場正因人們對動物健康的日益關注和獸醫服務需求的不斷成長而顯著擴張。動物用藥品包括用於治療和預防動物疾病的藥物，涵蓋家畜和伴侶動物。寵物數量的增加和動物保健支出的成長是推動市場成長的主要因素。此外，畜牧業的擴張和疾病預防的需求也促進了市場成長。

推動市場成長的因素包括藥物研發的進步，以及創新藥物和疫苗的開發。人們對通用感染疾病的認知不斷提高，以及對預防醫學的需求日益成長，也促進了市場成長。獸醫服務的擴展和先進治療方法的廣泛應用，也有助於提高藥物和疫苗的普及率。此外，政府促進動物健康和福利的措施也對市場成長起到了推動作用。

動物用藥品市場預計將持續創新發展。各公司可望專注於研發標靶治療和提高藥物療效。生物技術和先進研究技術的融合將進一步促進產品研發。隨著動物健康日益受到重視，動物用藥品需求預計將顯著成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為深入了解競爭動態和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球動物用藥品市場：依產品類型分類

  • 市場分析、洞察與預測
  • 藥品（抗感染藥物、抗發炎藥物、驅蟲藥）
  • 疫苗（去活化疫苗、減毒疫苗、重組疫苗等）
  • 藥用飼料添加劑（胺基酸、抗生素、抗菌劑）

第5章：全球動物用藥品市場：依適應症分類

  • 市場分析、洞察與預測
  • 感染疾病
  • 皮膚病
  • 疼痛
  • 整形外科疾病
  • 行為障礙
  • 其他

第6章 全球動物用藥品市場：依動物類型分類

  • 市場分析、洞察與預測
  • 生產動物/牲畜
  • 伴侶動物

第7章 全球動物用藥品市場：依給藥途徑分類

  • 市場分析、洞察與預測
  • 口服
  • 腸外給藥
  • 局部行政部門

第8章 全球動物用藥品市場：依通路分類

  • 市場分析、洞察與預測
  • 動物醫院
  • 動物診所
  • 零售藥房

第9章 全球動物用藥品市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Zoetis Inc
    • Merck & Co. Inc
    • Boehringer Ingelheim International GmbH
    • Elanco Animal Health Inc
    • Virbac SA
    • Dechra Pharmaceuticals PLC
    • Neogen Corporation
    • Phibro Animal Health Corporation
    • Vetoquinol
    • Norbrook
    • Hester Biosciences Limited
    • Ceva Sante Animale
    • Evonik Industries AG
    • Cargill Incorporated
    • Nutreco
簡介目錄
Product Code: VMR11216040

The global veterinary pharmaceuticals market size is expected to reach USD 83.88 Billion in 2034 from USD 41.72 Billion in 2025, growing at a CAGR of 8.07 during 2026-2034.This market is expanding significantly due to the increasing focus on animal health and the rising demand for veterinary care. Veterinary pharmaceuticals include drugs used to treat and prevent diseases in animals, including livestock and companion animals. The growing pet population and increasing expenditure on animal healthcare are key factors driving market growth. Additionally, the expansion of livestock farming and the need for disease prevention are contributing to market expansion.

Growth drivers include advancements in pharmaceutical research and the development of innovative drugs and vaccines. The increasing awareness of zoonotic diseases and the need for preventive care are also supporting market growth. The expansion of veterinary services and the availability of advanced treatment options are contributing to increased adoption. Furthermore, government initiatives promoting animal health and welfare are supporting market growth.

Looking ahead, the veterinary pharmaceuticals market is expected to witness continuous innovation and development. Companies are likely to focus on developing targeted therapies and improving drug efficacy. The integration of biotechnology and advanced research techniques will further enhance product development. As the importance of animal health continues to grow, the demand for veterinary pharmaceuticals is anticipated to increase significantly.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

  • Drugs (Anti-infective, Anti-inflammatory, Parasiticide)
  • Vaccines (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Others)
  • Medicated Feed Additives (Amino Acids, Antibiotics and Antimicrobials)

By Indication

  • Infectious Diseases
  • Dermatologic Diseases
  • Pain
  • Orthopedic Diseases
  • Behavioral Diseases
  • Other

By Animal Type

  • Production Animals/Livestock
  • Companion Animals

By Route of Administration

  • Oral Route
  • Parenteral Route
  • Topical Route

By Distribution Channels

  • Veterinary Hospitals
  • Veterinary Clinics
  • Retail Pharmacies

COMPANIES PROFILED

  • Zoetis Inc., Merck & Co. Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., Virbac SA, Dechra Pharmaceuticals PLC, Neogen Corporation, Phibro Animal Health Corporation, Vetoquinol, Norbrook, Hester Biosciences Limited, Ceva Sante Animale, Evonik Industries AG, Cargill Incorporated, Nutreco

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY PHARMACEUTICALS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Drugs (Anti-infective, Anti-inflammatory, Parasiticide) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Vaccines (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Medicated Feed Additives (Amino Acids, Antibiotics and Antimicrobials) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET: BY INDICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Indication
  • 5.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Dermatologic Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Orthopedic Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Behavioral Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY PHARMACEUTICALS MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Animal Type
  • 6.2. Production Animals/Livestock Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Route Of Administration
  • 7.2. Oral Route Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Parenteral Route Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Topical Route Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET: BY DISTRIBUTION CHANNELS 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Distribution Channels
  • 8.2. Veterinary Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Veterinary Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product Type
    • 9.2.2 By Indication
    • 9.2.3 By Animal Type
    • 9.2.4 By Route Of Administration
    • 9.2.5 By Distribution Channels
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product Type
    • 9.3.2 By Indication
    • 9.3.3 By Animal Type
    • 9.3.4 By Route Of Administration
    • 9.3.5 By Distribution Channels
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product Type
    • 9.4.2 By Indication
    • 9.4.3 By Animal Type
    • 9.4.4 By Route Of Administration
    • 9.4.5 By Distribution Channels
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product Type
    • 9.5.2 By Indication
    • 9.5.3 By Animal Type
    • 9.5.4 By Route Of Administration
    • 9.5.5 By Distribution Channels
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product Type
    • 9.6.2 By Indication
    • 9.6.3 By Animal Type
    • 9.6.4 By Route Of Administration
    • 9.6.5 By Distribution Channels
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL VETERINARY PHARMACEUTICALS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Zoetis Inc
    • 11.2.2 Merck & Co. Inc
    • 11.2.3 Boehringer Ingelheim International GmbH
    • 11.2.4 Elanco Animal Health Inc
    • 11.2.5 Virbac SA
    • 11.2.6 Dechra Pharmaceuticals PLC
    • 11.2.7 Neogen Corporation
    • 11.2.8 Phibro Animal Health Corporation
    • 11.2.9 Vetoquinol
    • 11.2.10 Norbrook
    • 11.2.11 Hester Biosciences Limited
    • 11.2.12 Ceva Sante Animale
    • 11.2.13 Evonik Industries AG
    • 11.2.14 Cargill Incorporated
    • 11.2.15 Nutreco